相关实验视频
Updated: May 13, 2025

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
[针对耐火性痛风的基于尿酶的治疗方法的创新视角]
1Department of Rheumatology and Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.
耐火性痛风可以通过尿酶疗法治疗,这种疗法可以分解尿酸. 本综述讨论了用于管理耐火性痛风和减少抗尿酶抗体的佩格洛酶和拉斯布里酶.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 类风湿病学 类风湿病学
背景情况:
- 耐火性痛风是一个重大的临床挑战.
- 外源性尿酶通过将尿酸降解为阿兰因提供酶替代疗法.
- 已批准的尿类药物包括佩格洛 (美国) 和拉斯布里卡斯 (中国).
研究的目的:
- 详细阐述尿类药物的治疗痛风的机制.
- 审查当前 pegloticase 在耐火性痛风管理中的状态.
- 讨论拉斯布里卡斯的应用和减少抗尿酶抗体的策略.
主要方法:
- 关于尿类药物及其临床应用的文献综述.
- 分析当前的研究和临床实践.
- 讨论治疗疗效和降低抗体的策略.
主要成果:
- 佩格洛提卡斯在美国被批准用于耐火性痛风;拉斯布里卡斯在中国被批准用于儿童白血病/淋巴瘤.
- 尿治疗迅速降低血清尿酸,并溶解多菲.
- 目前正在进行的研究重点是减轻抗尿酶抗体反应.
结论:
- 尿酶药物代表了耐火性痛风的宝贵治疗选择.
- 合理使用这些药物需要了解它们的机制和临床应用.
- 需要进一步的研究来优化疗效和最小化免疫性.
更多相关视频
10:02Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril
Published on: October 3, 2020
08:46Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides
Published on: July 26, 2018
相关概念视频
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Renal Drug Excretion: Tubular Secretion
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Action of Diuretics
Antihypertensive Drugs: Direct Renin Inhibitors